Rebastinib, CAS [[1020172-07-9]]

Product Overview

• Article Name: Rebastinib, CAS [[1020172-07-9]]
• Biozol Catalog Number: TGM-T2640
• Supplier Catalog Number: T2640
• Alternative Catalog Number: TGM-T2640-1MLX10MM(INDMSO),TGM-T2640-1MG,TGM-T2640-5MG,TGM-T2640-10MG,TGM-T2640-25MG,TGM-T2640-50MG,TGM-T2640-100MG
• Manufacturer: TargetMol
• Category: Biochemikalien
• Alternative Names: DCC2036 , DCC 2036 , DCC-2036

Product Description

DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.

Product Properties

• Molecular Weight: 553.59
• Purity: 99.84%
• CAS Number: [1020172-07-9]
• Formula: C30H28FN7O3
• Target: Apoptosis|||FLT|||Bcr-Abl|||Src

Images

T2640